Thymalin

Key points

• Thymalin is an extract of small peptides from the thymus, the gland that helps train the immune system.
• It is one of the Russian peptide bioregulators, marketed to support immunity, especially with age.
• Most of the research comes from a single group, and independent evidence is limited.
• It is not a licensed medicine in the UK and is sold for research use.

Quick facts

What it is

Thymus peptide bioregulator

Marketed for

Immune support, especially with age

UK status

Not a licensed medicine; sold for research use

Human evidence

Mostly from one research group

How it works

The thymus produces signals that guide the immune system, particularly the T cells. Thymalin is a mix of thymus peptides said to support this, which is the basis for marketing it to older people whose thymus activity has declined. How well it works in people, and exactly how, is not well established outside its country of origin.

What the evidence shows

There are studies from Russia, including some in older people, reporting immune and general health effects. Independent trials of the kind needed to license a medicine in the UK are lacking, so the claims should be treated with caution.

What it does not settle

• Independent evidence outside its country of origin is limited.
• Long term safety in wide use is not well established.
• Products sold online are not quality assessed.

Side effects

Less common but serious

• Because there is no UK licensed product, the dose, purity and contents of material bought online cannot be verified.

Report any suspected side effect through the MHRA Yellow Card scheme.

UK legal status and access

Thymalin has no UK marketing authorisation, so it is not a licensed medicine and is not offered by registered clinics or pharmacies. It is sold online for research use.

Common questions